chr14-74480265-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 2P and 16B. PM2BP4_StrongBP6_Very_StrongBS1
The ENST00000555619.6(NPC2):c.*9T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000404 in 1,614,126 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0022 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00021 ( 0 hom. )
Consequence
NPC2
ENST00000555619.6 3_prime_UTR
ENST00000555619.6 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.565
Genes affected
NPC2 (HGNC:14537): (NPC intracellular cholesterol transporter 2) This gene encodes a protein containing a lipid recognition domain. The encoded protein may function in regulating the transport of cholesterol through the late endosomal/lysosomal system. Mutations in this gene have been associated with Niemann-Pick disease, type C2 and frontal lobe atrophy. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 14-74480265-A-G is Benign according to our data. Variant chr14-74480265-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 502347.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-74480265-A-G is described in Lovd as [Likely_benign]. Variant chr14-74480265-A-G is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00224 (341/152274) while in subpopulation AFR AF= 0.00784 (326/41562). AF 95% confidence interval is 0.00714. There are 0 homozygotes in gnomad4. There are 151 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NPC2 | NM_006432.5 | c.*9T>C | 3_prime_UTR_variant | 5/5 | ENST00000555619.6 | NP_006423.1 | ||
NPC2 | NM_001363688.1 | c.*353T>C | 3_prime_UTR_variant | 4/4 | NP_001350617.1 | |||
NPC2 | NM_001375440.1 | c.*9T>C | 3_prime_UTR_variant | 4/4 | NP_001362369.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NPC2 | ENST00000555619.6 | c.*9T>C | 3_prime_UTR_variant | 5/5 | 1 | NM_006432.5 | ENSP00000451112 | P4 |
Frequencies
GnomAD3 genomes AF: 0.00224 AC: 341AN: 152156Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
341
AN:
152156
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000650 AC: 162AN: 249420Hom.: 1 AF XY: 0.000519 AC XY: 70AN XY: 134998
GnomAD3 exomes
AF:
AC:
162
AN:
249420
Hom.:
AF XY:
AC XY:
70
AN XY:
134998
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000213 AC: 311AN: 1461852Hom.: 0 Cov.: 32 AF XY: 0.000197 AC XY: 143AN XY: 727236
GnomAD4 exome
AF:
AC:
311
AN:
1461852
Hom.:
Cov.:
32
AF XY:
AC XY:
143
AN XY:
727236
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00224 AC: 341AN: 152274Hom.: 0 Cov.: 32 AF XY: 0.00203 AC XY: 151AN XY: 74456
GnomAD4 genome
AF:
AC:
341
AN:
152274
Hom.:
Cov.:
32
AF XY:
AC XY:
151
AN XY:
74456
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Benign, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | May 31, 2017 | - - |
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | May 09, 2020 | See Variant Classification Assertion Criteria. - |
Likely benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Niemann-Pick disease, type C1 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at